Cargando…
COVID-19 cancer conundrum—evidence driving decisions or the lack of it?
Autores principales: | Joharatnam-Hogan, Nalinie, Khan, Khurum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282465/ https://www.ncbi.nlm.nih.gov/pubmed/32517687 http://dx.doi.org/10.1186/s12916-020-01649-z |
Ejemplares similares
-
Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes—The University College London Hospital (UCLH) Experience
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2020) -
The Long COVID Conundrum
por: Gaffney, Adam W.
Publicado: (2022) -
COVID-19 in cancer patients on systemic anti-cancer therapies:
outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London)
cohort study
por: Crolley, Valerie E., et al.
Publicado: (2020) -
COVID-19, diabetes mellitus and ACE2: The conundrum
por: Pal, Rimesh, et al.
Publicado: (2020) -
Short telomeres and severe COVID-19: The connection conundrum
por: Aviv, Abraham
Publicado: (2021)